Amuvatinib
Amuvatinib (MP470) is an orally available small molecule investigational agent with potential antitumor properties. It has been studied in vitro and in vivo for its activity against various cancer cell lines, particularly in research focusing on receptor tyrosine kinase inhibition and DNA repair pathways.
Product Specifications
CAS Number
850879-09-3
Product Name Alternative
DNA Synthesis, DNASynthesis, cRET, CD117, Cluster of differentiation antigen 135, CD135, c-Kit, cKit, c-Kit (D816H), cMet, cMet/HGFR, c-Met, c-Met/HGFR, Apoptosis, Amuvatinib, inhibit, MP 470, MP470, MP-470, Platelet-derived growth factor receptor, PDGFR, Fms like tyrosine kinase 3, FLT3, FLT3 (D835Y), Inhibitor, HGFR, HPK56, HPK-56, HPK 56, RAD51, PDGFRα (V561D), RNA Synthesis, RNASynthesis, RET, SCFR
Field of Research
Cardiovascular Research, Cell Biology, Molecular Biology, Signal Transduction
Purity
98.48% (May vary between batches)
Solubility
DMSO:50 mg/mL (111.73 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.47 mM)
Smiles
C (NCC=1C=C2C (=CC1) OCO2) (=S) N3CCN (C4=C5C (C=6C (O5) =CC=CC6) =NC=N4) CC3
Molecular Formula
C23H21N5O3S
Molecular Weight
447.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
